Neuromodulation trials

Functional and Quality of Life Effects of the Mollii Neuromodulatory Suit in Patients With Stroke and Multiple Sclerosis

RecruitingNCT07333222Phase: NAStarted 2026-01-12

Summary

* Objective assessment of clinical symptoms resulting from stroke, as well as changes in mobility and quality of life, and determination of changes resulting from therapies * Objective assessment of t

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
99 Years

Locations

Somogy County Kaposi Mór Teaching HospitalKaposvár, Somogy County, Hungary

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT07333222